Morgan Stanley Upgrades Lufax Holding to Overweight, Lowers Price Target to $13
Morgan Stanley upgrades Lufax Holding (NYSE:LU) from Equal-Weight to Overweight and lowers the price target from $14.8 to $13.
54 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) climbed 79.3% to $14.93 after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy adult volunteers.
Understanding Lufax Holding’s Unusual Options Activity
Shares of Lufax Holding (NYSE:LU) saw some unusual options activity on Tuesday. Following the unusual option alert, the stock price moved up to $8.25.
Lufax Holding Q2 ADS $0.29 Beats $0.23 Estimate
Lufax Holding (NYSE:LU) reported quarterly earnings of $0.29 per share which beat the analyst consensus estimate of $0.23 by 26.09 percent.
Earnings Scheduled For August 9, 2021
Companies Reporting Before The Bell
• Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million.
Stocks That Hit 52-Week Lows On Thursday
During Thursday's morning session, 77 companies made new 52-week lows.
Stocks That Hit 52-Week Lows On Friday
Before 10 a.m. ET Friday, 117 stocks made new 52-week lows.
Stocks That Hit 52-Week Lows On Tuesday
Before 10 a.m. ET Tuesday, 64 stocks made new 52-week lows.